A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during ...

Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status ...

2024 ABPI Code update has launched – what’s next for pharma and QR codes? The long-anticipated update to the ABPI Code of ...

How the UK medical cannabis market is tackling supply chain strain ...

Cytomos has announced that it has raised $5m in an oversubscribed funding round to scale up production of its cell analysis ...

There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive ...

The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles ...

There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive revolution ...

Tessellate BIO has appointed Dr Lara Boyd as Chief Business Officer.

AC Immune SA has reported encouraging interim results from its phase 2 VacSYn clinical trial of ACI-7104.056, an ...

Eran Harary, Senior Vice President of Global Early Clinical Development at Teva, said: “This collaboration will provide ...

Osivax, a biopharmaceutical company developing vaccines for broad-spectrum protection against infectious viruses, has ...